Playbook: What It Takes to be First to Market  

As the biopharma industry grows ever more competitive, with multiple companies developing therapies for the same indications, being first to market carries a significant advantage.  

However, few drug developers have the internal resources to streamline process development, scaling and manufacturing, all while maintaining regulatory excellence. And developers increasingly look outside their organizations for the support they need to bring novel therapies to market.  

Against this backdrop, contract development and manufacturing organizations (CDMOs) play a key role in successful launches – and finding the right partner is essential to hit key development milestones, including successful process performance qualification (PPQ).  

Here, we’ll discuss how Rentschler Biopharma helped its client beat rival companies to become first to market, condensing GMP1 to PPQ development into an “impossible” 12 months.  

In this playbook you’ll learn how Rentschler Biopharma …  

• Leveraged its global expertise to streamline and expedite process development and PPQ.  

• Developed robust, scalable processes to support commercialization.  

• Applied the “secrets to success” that allowed our client to condense GMP to PPQ development into 12 months — and beat rival companies to become first to market.  

Download white Playbook here: